NLS Pharmaceutics Announces Preclinical Results Confirming the Potential Benefit and Safety Profile of NLS-4 for Circadian Rhythm Dysregulation and Chronic Fatigue Syndrome in Long-Covid Model

Stock Information for NLS Pharmaceutics Ltd.

Loading

Please wait while we load your information from QuoteMedia.